A small cup and a large mug of black coffee side by side on a wooden tray in soft daylight, a few roasted beans beside them

Moderate coffee intake means keeping caffeine within population guidance while choosing an amount and timing that suit you. For healthy, non-pregnant adults, EFSA identifies up to 400 mg a day, spread throughout the day, as raising no safety concerns, but individual sensitivity, pregnancy and medicines can make a lower intake appropriate.

In short

  • Count caffeine from all sources, including tea, chocolate, energy drinks, supplements and some medicines.
  • The adult benchmarks are up to 200 mg in a single dose and 400 mg across the day, not targets to reach.
  • Even 100 mg close to bedtime can affect sleep in some adults.
  • During pregnancy, NHS advice is no more than 200 mg daily from all sources.
  • Genetics contributes to sensitivity, but medicines, smoking, pregnancy and your actual symptoms matter too.

What does moderate coffee intake mean?

There is no universal number of cups that defines moderation. A cup describes a container, not a caffeine dose, and coffee strength and serving size vary.

EFSA’s adult benchmarks concern the general healthy population. They are not personalised advice for someone with a medical condition or taking an interacting medicine, nor a promise that everyone will feel comfortable at those levels.

A useful working definition is therefore: an intake within the relevant guidance that does not interfere with your sleep or cause troublesome symptoms. If a smaller amount leaves you shaky or restless, there is no reason to work upwards towards the population benchmark.

Count milligrams, not just mugs

The NHS gives approximate figures of 100 mg for a mug of instant coffee, 140 mg for a mug of filter coffee and 75 mg for a mug of tea. These are reference estimates, not measurements of your particular drink.

Using those estimates, one instant coffee, one filter coffee and one tea would contribute:

100 mg + 140 mg + 75 mg = 315 mg of caffeine.

That is before chocolate, energy drinks or caffeine-containing medicines. Ask the manufacturer or retailer for information about your usual product where available, and treat an unknown amount as uncertain rather than caffeine-free.

Our coffee and health guide puts this practical question alongside the wider evidence without turning moderation into a prescribed number of coffees.

A hand moves a coffee cup away from a bedside table, leaving a glass of water.

Why the same coffee affects people differently

Two processes help explain the difference: how quickly your body removes caffeine, and how strongly you respond while it is present. They overlap, but they are not interchangeable.

Metabolism: how quickly caffeine is cleared

Caffeine is broken down mainly through processes involving the liver enzyme CYP1A2. An enzyme is a protein that helps a chemical reaction happen; the CYP1A2 gene helps determine how this particular enzyme is produced and regulated.

A gene variant, also called a polymorphism, is a difference in DNA sequence between people. Some CYP1A2 variants are associated with differences in enzyme activity, which has encouraged the shorthand descriptions “fast” and “slow” caffeine metabolisers.

Those labels are incomplete. In an influential human study, differences between the examined CYP1A2 genotypes were apparent in smokers but not statistically significant in non-smokers using the study’s measures. The finding illustrates how genetic variation and environmental exposure can interact.

Your CYP1A2 result is therefore not a complete explanation of personal tolerance. It does not capture pregnancy, interacting medicines or sensitivity to caffeine’s effects on the brain.

Sensitivity: how strongly caffeine affects you

Caffeine blocks adenosine receptors, sites through which adenosine helps regulate processes including sleep and wakefulness. ADORA2A is the gene associated with one of these receptor types.

Human caffeine-challenge studies have linked ADORA2A variation with differences in caffeine-induced anxiety and sleep responses. This is evidence of a contribution, not a genetic verdict that somebody will always sleep badly after coffee.

The distinction matters: clearing caffeine relatively quickly does not necessarily mean feeling comfortable after it. Likewise, being able to drink coffee without obvious jitters does not measure how much caffeine remains in your body. See caffeine’s effects on health for the broader mechanisms.

Half-life explains why timing matters

Caffeine’s half-life is the time taken for the body to eliminate half the amount present. EFSA describes an average of approximately four hours in healthy adults, with a range of two to eight hours.

For illustration, assume a person starts with 100 mg and has a four-hour half-life, with no further caffeine consumed. About 50 mg would remain after four hours and 25 mg after eight hours. This simplified calculation explains the principle; it is not a personalised prediction.

Repeated drinks add new caffeine while earlier doses are still being cleared. When reviewing your intake, record the time of the last drink as well as the daily total.

There is no single afternoon cut-off that suits everyone. If sleep is troublesome, a practical experiment is to move caffeine earlier and reduce the amount, rather than relying only on whether you feel stimulated at bedtime.

Medicines, contraception and smoking can change your response

If familiar coffee suddenly feels stronger, review what else has changed before assuming your genes explain it.

Medicines that slow caffeine breakdown

Two established examples are:

  • Fluvoxamine: its UK prescribing information identifies inhibition of CYP1A2 and warns that caffeine blood levels can increase. It advises reducing high caffeine intake when adverse effects such as tremor, palpitations, restlessness or insomnia occur.
  • Ciprofloxacin: this antibiotic inhibits CYP1A2, and its UK prescribing information reports increased caffeine concentrations during concurrent use.

These examples are not a complete interaction list. Ask a pharmacist to check your prescribed medicines, over-the-counter products and supplements, particularly when starting or stopping treatment. Do not stop or alter prescribed treatment to accommodate coffee.

Oral contraception and pregnancy do not have one fixed multiplier

Oestrogen-containing oral contraceptives can slow caffeine clearance. An older, small pharmacokinetic study reported an average half-life of 10.7 hours among oral contraceptive users, compared with 6.2 hours among women not using them.

Pregnancy can also substantially prolong clearance. A separate study reported an average half-life of 10.5 hours during the final four weeks of pregnancy, compared with three hours in non-pregnant women.

These findings support the direction of the effect, but not a universal claim that contraception and pregnancy both double everyone’s half-life. Formulation, pregnancy stage and individual variation matter; the study averages are not personal countdown clocks.

Smoking accelerates clearance

Substances in tobacco smoke increase CYP1A2 activity, which can accelerate caffeine metabolism. After stopping smoking, the same coffee routine can produce greater caffeine exposure as that enzyme-inducing effect wears off.

This is a reason to review caffeine during smoking cessation, not a reason to continue smoking. A pharmacist or stop-smoking adviser can also check medicines affected by the change.

Pregnancy, breastfeeding and age

Pregnancy

NHS advice is to have no more than 200 mg of caffeine daily during pregnancy, counting all sources. Feeling unaffected by coffee does not override pregnancy guidance.

Speak to your midwife, GP or pharmacist if you are unsure about your intake or a medicine containing caffeine. Do not use a “fast metaboliser” label as permission to exceed the recommendation.

Breastfeeding

The NHS breastfeeding page retrieved for this article says it is sensible to cut caffeine out because it can make a baby restless. If you do consume it, that page advises trying not to exceed 300 mg daily.

EFSA’s assessment uses a lower no-concern level of 200 mg daily for breastfeeding women. These are different published benchmarks, not interchangeable statements. For a cautious approach, keep within the lower level and seek advice from your health visitor, GP or pharmacist if your baby seems affected.

Children, adolescents and older adults

The adult daily benchmark should not be transferred to children. EFSA assesses children and adolescents using body-weight-based guidance, rather than a universal adult allowance.

For older adults, age alone does not provide a personalised coffee limit. EFSA identifies age, medication use and liver health among factors affecting half-life. Review the combination of sleep, symptoms, health conditions and medicines rather than assuming a long-established routine must still suit you.

Listening to your body without diagnosing yourself

Useful warning signs include restlessness, shakiness, difficulty sleeping and a noticeably pounding or racing heartbeat. They justify reviewing caffeine, but they do not prove caffeine is the cause.

A simple diary can make the review more useful:

  1. Record the drink or product. Include serving size and any published caffeine information.
  2. Write down the time. Include tea, supplements and medicines, not just coffee.
  3. Note what happened. Record symptoms and how you slept, without assuming a cause.
  4. Make a manageable change. Try less caffeine or earlier timing. If reducing a daily habit, gradual reduction can make withdrawal less unpleasant.
  5. Review persistent problems with a professional. Take the diary and your medicine list to a pharmacist or GP.

This is a practical observation tool, not a diagnostic test. Do not deliberately repeat a drink that caused a severe reaction to see whether it happens again.

Seek GP advice for recurring or increasingly frequent palpitations. Call 999 if current palpitations do not go away, or occur with chest pain, shortness of breath, feeling faint or fainting. Do not dismiss these symptoms as “just coffee”.

What the evidence can and cannot tell you

The strength descriptions below are editorial assessments of how useful each finding is for this question, not a formal clinical grading system.

Claim Type of evidence Strength and limitation Source
Adult caffeine benchmarks provide population guidance Authority risk assessment Strong basis for general guidance, not an individual prescription EFSA, 2015
CYP1A2 variation contributes to metabolism differences Human genotype and caffeine-metabolism study Supports a contribution; environmental context matters Sachse and colleagues, 1999
ADORA2A variation contributes to anxiety and sleep responses Controlled caffeine challenges and human genetic association research Mechanistic support; limited individual predictive value Childs and colleagues, 2008; Rétey and colleagues, 2007
Pregnancy and oral contraceptives can prolong caffeine clearance Human pharmacokinetic studies Direct measurements, but small studies do not establish one universal multiplier Knutti and colleagues, 1982; Patwardhan and colleagues, 1980
Fluvoxamine and ciprofloxacin can increase caffeine exposure Authorised prescribing information Established interactions requiring medicine-specific advice UK product information, 2026

Research about possible coffee health benefits answers a different question from whether your present intake suits you. Moderation and sensitivity are best judged using the relevant guidance, your circumstances and appropriate professional advice, not a comparison with the person drinking beside you.

FAQ

Is decaf suitable if I am caffeine-sensitive?

Decaf can help reduce caffeine intake, but it is not caffeine-free. If you react to small amounts, residual caffeine may still matter. Check product information where available, and discuss persistent symptoms with a pharmacist or GP rather than assuming that changing to decaf rules caffeine in or out as the cause.

Can a genetic test tell me my ideal coffee intake?

A genetic result alone cannot establish your ideal intake. CYP1A2 and ADORA2A research helps explain variation between people, but it does not account for all medicines, health circumstances or symptoms. Treat a result as limited background information, not permission to exceed guidance or a substitute for investigating a troublesome reaction.

Should everyone in an office follow the same coffee limit?

No, a shared coffee machine does not imply a shared tolerance. A useful workplace approach is to make decaf and non-caffeinated drinks easy to choose, avoid encouraging repeated coffees, and let people manage their own intake. Individual pregnancy or medicine advice belongs with the person and their healthcare professional.

Where to go next

Read Coffee and Health for the wider evidence, then Caffeine and Health for more detail on caffeine’s actions. Coffee Health Benefits helps distinguish possible benefits from reasons to increase intake, while Antioxidants in Coffee explains the other compounds in coffee.

Sources

  1. European Food Safety Authority. Caffeine, current topic page summarising the 2015 safety assessment, retrieved November 2026.
    https://www.efsa.europa.eu/en/topics/topic/caffeine

  2. European Food Safety Authority. EFSA explains risk assessment: Caffeine, 2015.
    https://www.efsa.europa.eu/sites/default/files/corporate_publications/files/efsaexplainscaffeine150527.pdf

  3. Food Standards Agency. Guidance for food business operators on food supplements containing caffeine, 2024. Used for its summary of caffeine sources and adult guidance, not as legislation governing coffee consumption.
    https://www.gov.uk/government/publications/guidance-for-food-operators-on-supplements-containing-caffeine/guidance-for-food-business-operators-on-food-supplements-containing-caffeine

  4. NHS. Foods to avoid in pregnancy, reviewed June 2026.
    https://www.nhs.uk/pregnancy/keeping-well/foods-to-avoid/

  5. NHS Best Start in Life. Food and drinks to avoid when breastfeeding, undated webpage, retrieved November 2026.
    https://www.nhs.uk/best-start-in-life/baby/feeding-your-baby/breastfeeding/healthy-diet-when-breastfeeding/food-and-drinks-to-avoid-when-breastfeeding/

  6. Sachse C and colleagues, British Journal of Clinical Pharmacology. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine, 1999.
    https://pubmed.ncbi.nlm.nih.gov/10233211/

  7. Childs E and colleagues, Neuropsychopharmacology. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety, 2008.
    https://pubmed.ncbi.nlm.nih.gov/18305461/

  8. Rétey JV and colleagues, Clinical Pharmacology & Therapeutics. A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep, 2007.
    https://pubmed.ncbi.nlm.nih.gov/17329997/

  9. Patwardhan RV and colleagues, Journal of Laboratory and Clinical Medicine. Impaired elimination of caffeine by oral contraceptive steroids, 1980.
    https://pubmed.ncbi.nlm.nih.gov/7359014/

  10. Knutti R and colleagues, Archives of Toxicology Supplement. The effect of pregnancy on the pharmacokinetics of caffeine, 1982.
    https://pubmed.ncbi.nlm.nih.gov/6954898/

  11. Viatris, electronic Medicines Compendium. Faverin 50 mg Film-coated Tablets: Summary of Product Characteristics, revised February 2026, sections 4.5 and 10.
    https://www.medicines.org.uk/emc/product/1169/smpc

  12. Sun Pharma, electronic Medicines Compendium. Ciprofloxacin 250 mg film-coated tablets: Summary of Product Characteristics, revised October 2026, sections 4.4, 4.5 and 10.
    https://www.medicines.org.uk/emc/product/4341/smpc

  13. Medicines and Healthcare products Regulatory Agency. Smoking and smoking cessation: clinically significant interactions with commonly used medicines, Drug Safety Update, October 2009; GOV.UK publication 2014.
    https://www.gov.uk/drug-safety-update/smoking-and-smoking-cessation-clinically-significant-interactions-with-commonly-used-medicines

  14. US Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much?, current consumer webpage, retrieved November 2026.
    https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much

  15. NHS. Heart palpitations, reviewed March 2026.
    https://www.nhs.uk/symptoms/heart-palpitations/

Researched using live NHS, EFSA, FSA and medicines guidance, alongside original human studies; calculations and practical suggestions are identified separately from research findings.

Last checked: November 2026